Veličina fonta
Sivi ton

Studenti, nastavnici i ostali zaposlenici koji imaju simptome infekcije ili dokazanu bolest COVID-19 ili su bili u bliskom kontaktu s oboljelim osobama moraju se obvezno javiti elektroničkom poštom na adresu:

Djelatnici, Katedre, Studenti, Znanost
6. 6. 2017.


The IUPHAR GI Section was established in 1994. During the past 20 years, numerous symposia have been successfully organized to exchange original ideas and preliminary results among the members. Several Nobel laureates have taken part in, including James Black, Barry Marshall, Robin Warren, and Robert J. Lefkowitz.

The primary objective of the IUPHAR GI Section is to provide the state-of-the-art of GI pharmacology regarding the properties and actions of new drugs as well as the new properties and new actions of old drugs for GI diseases, e.g. nonsteroidal anti-inflammatory drugs (NSADS)-induced GI mucosal damage, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), GI cancers and obesity.

The specific objectives:

  1. Promoting basic and clinical pharmacology research and education by frequently organizing scientific symposia
  2. Promoting international collaborations by planning and coordinating research programs
  3. Providing consultancy and drug testing services for pharmaceutical companies

IUPHAR program

Details about IUPHAR GI SECTION MEETING 2017 are available here.